Author

Liancheng Lu

Virginia Tech

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Dallas B. FliesiD· 1 shared David B. SykesiD· 1 shared Ella P. DennisiD· 1 shared F. ZengiD· 1 shared Jennifer MunkleyiD· 1 shared Kirsty HodgsoniD· 1 shared Libby BlencoeiD· 1 shared Margarita Orozco‐MorenoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Dallas B. FliesORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Siglec-15 is a glyco-immune checkpoint in prostate cancer regulating immune evasion and metastasis

Nicoll Matthews, F. Zeng, Kirsty Hodgson, Matthew Fisher, Ziqian Peng, Libby Blencoe, Margarita Orozco‐Moreno, Ella P. Dennis, Liancheng Lu, Michelle Anne Lawson, Shenglin Mei, David B. Sykes, Dallas B. Flies, Richard Beatson, Ning Wang, Jennifer Munkley

Siglec-15 is found on prostate tumour cells, macrophages and osteoclasts; antibody blockade reduced macrophage immunosuppression, osteoclast formation and tumour growth in mice (CD8+ T-cell-dependent).

bioRxiv · Aug 10, 2026 · PreprintCancer Biology✦ In-depth digest